Navigation Links
Golden Meditech Shareholders Approves of Name Change
Date:3/15/2010

HONG KONG, March 15 /PRNewswire-Asia/ -- Golden Meditech Holdings Limited ("Golden Meditech" or "the Group"; Stock Code: 801), China's leading integrated healthcare device and service enterprise, is pleased to announce today that the Group's shareholders (the "Shareholders") have approved at an Extraordinary General Meeting (the "EGM") held today, a special resolution as proposed by the board of directors ("the Board") to change the Group's name into "Golden Meditech Holdings Limited."

The Group's diversified business portfolio currently includes the core and wholly-owned operation of Beijing Jingjing Medical Equipment Co., Ltd., renowned as China's first and largest manufacturer of autologous blood recovery device, and a hospital management arm that is the first foreign-owned entity in China to offer nationwide hospital management and consultancy services. In addition, the Group also has a majority stake in China Cord Blood Corporation ( CO), the first and largest cord blood bank operator in China, and FunTalk China Holdings Limited (NDAQ: FTLK), a thriving fast-moving consumer electronics goods retailer in China.

Commenting on the significance of name change, Mr. KAM Yuen, Chairman and CEO of the Group, said, "While we already enjoy dominant positions in all of the different business market segments which we operate, our expertise and in- depth knowledge in China market has rendered us in an excellent position to capture the immense opportunities arising from China's rapidly expanding and thriving medical and healthcare industries and beyond. Going forward, we believe the new names will better reflect our corporate vision as underpinned by the Group's strategic developments, effectively highlighting the diversity and depth of our diversified and growing healthcare operations built around its core competences in healthcare and medical industry."

About the Group:

Golden Meditech Holdings Limited is China's leading integrated healthcare device and service operator, and the first medical device enterprise that was publicly listed outside of the PRC on the Stock Exchange of Hong Kong Limited (HKEX). Golden Meditech is a first-mover in China's medical devices, cord blood banking, having established dominant positions in these respective areas over the years, thanks to its strengths in innovation and market expertise, as well as its ability in capturing emerging market opportunities. Going forward, the Group will continue its pursuit in becoming China's leading integrated medical group both through organic growth and strategic expansion.

    For inquiry, please kindly contact:

     Investor Relations Division
     Golden Meditech Holdings Limited
     Address: 48/F, Bank of China Tower,
              1 Garden Road,
              Central, Hong Kong.
     Tel:     +852-3605-8138
     Fax:     +852-3605-8181
     Email:   ir@goldenmeditech.com

SOURCE Golden Meditech Holdings Limited

Back to top
'/>"/>
SOURCE Golden Meditech Holdings Limited
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Golden Corrals Good Health Recipe for the Flu Season
2. National Energy Services Receives Repeat Orders From Golden Living and Cathedral Rock Skilled Nursing Facilities
3. Giving Back to the Community Golden Corral Style
4. Golden Doctor of Chiropractic Elected President of the Colorado Chiropractic Association
5. Kaiser Permanente and Golden State Warriors Team Up to Fight Childhood Obesity
6. Histochemistry is the golden standard in the diagnosis of carcinosarcomas
7. Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross and Lifetime Television Deliver 20 Million Online Petition Signatures to Capitol Hill to Urge Congress to Stop Drive-Through Mastectomies
8. Author Elizabeth Golden and Dancer Sarah Patellos to Serve as National Spokespersons for the National Scoliosis Foundation
9. American Airlines Honors Flight Attendants at Golden Heart Awards Ceremony
10. Golden State Medical Supply Selects IBM Technology to Comply With California Prescription Drug Pedigree Regulations
11. Golden Rainbow Takes a Musical Journey for Its 22nd Annual Ribbon of Life Production Show
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... ... 'Tis the season for family, festivity, food and fun! Temptation abounds, and parties ... healthy, staying active, and taking medication and doing daily foot health checks (a must ... trips, parties and family gatherings can take their toll on our feet during the ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... authorized OSHA Training Institute Education Center headquartered in Northern California, has announced the ... providing occupational safety and health training to public sector employees. , “The primary ...
(Date:12/5/2016)... ... 2016 , ... Edward Buckingham MD , and the ... the newest Sciton laser in January 2017. The Halo is the first and ... wavelengths for exceptional results. Outperforming more traditional lasers, the innovative Halo automatically customizes ...
(Date:12/5/2016)... Petersburg, Fla. (PRWEB) , ... December 05, 2016 , ... ... concussions have on the growing brains of young athletes. Over the course of three ... the head through unique mouth guards. The mouth guards, equipped with special sensors, will ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... company will provide alerting technology to Central Illinois Health Information Exchange (CIHIE) ... in federal funds as the sole sub-recipient participating with the Illinois Health ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... LAKE OSWEGO, Ore. , Dec. 5, 2016 /PRNewswire/ ... in the BioInsight clinical study. The study evaluates the ... 2 insertion procedure in an office setting. ... ProMRI ® technology that is placed underneath a ... atrial fibrillation and syncope (fainting). Atrial fibrillation is a ...
(Date:12/5/2016)... and Gateway Health proudly announce a dynamic collaboration that will ... members with specific high risk needs. In an ... of consumers, Wellbridge combines technology and population expertise with a ... daily behaviors and lifestyle. ... , , "Dealing ...
(Date:12/5/2016)... PARSIPPANY, N.J. , Dec. 5, ... Sankyo) today announced preliminary safety and efficacy data ... investigational oral selective MDM2 inhibitor, suggesting that DS-3032 ... including relapsed/refractory acute myeloid leukemia (AML) and high-risk ... escalation part of the phase 1 study of DS-3032 ...
Breaking Medicine Technology: